Listings on the PBS for Aboriginal and Torres Strait Islander people

Page last updated: 1 June 2017

The Australian Government is committed to improving the capability of the Pharmaceutical Benefits Scheme (PBS) to better meet the needs of Aboriginal and Torres Strait Islander people. The Pharmaceutical Benefits Advisory Committee is assisting this goal by evaluating and recommending the listing of medications specifically to help with the health needs of Aboriginal and Torres Strait Islander people.

This list details all PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people. For more information about PBS access by Aboriginal and Torres Strait Islander people, see Improving the capacity of the PBS to meet particular Aboriginal and Torres Strait Islander health needs in the explanatory notes, or contact us at pbs-indigenous@health.gov.au.

 

 

Restricted Benefit

For treatment of a patient identifying as Aboriginal or Torres Strait Islander

8985X FERROUS FUMARATE, ferrous fumarate 200 mg (equivalent to 65.7 mg of elemental iron) tablet, 60 (Ferro-tab)

 

Restricted Benefit

For treatment of a patient identifying as Aboriginal or Torres Strait Islander

9011G FERROUS FUMARATE + FOLIC ACID, ferrous fumarate 310 mg (equivalent to 100 mg elemental iron) + folic acid 350 microgram tablet, 60 (Ferro-f-tab)

 

Restricted Benefit

For treatment of a patient identifying as Aboriginal or Torres Strait Islander

11112W CHLORAMPHENICOL, chloramphenicol 0.5% eye drops, 10 mL (Chlorsig)

 

Note:
No increase in the maximum quantity or number of units may be authorised.
Note:
No increase in the maximum number of repeats may be authorised.
Authority Required (STREAMLINED)
6647 Staphylococcus aureus infection
Clinical criteria:
Patient must have nasal colonisation with the bacteria.
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.

9440W Mupirocin, mupirocin 2% (20 mg/g) ointment, 3 g (Bactroban)

 

Restricted Benefit
Nicotine dependence
Clinical criteria:
The treatment must be the sole PBS-subsidised therapy for this condition.
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.
Note:
Only 2 courses of PBS-subsidised nicotine replacement therapy may be prescribed per 12-month period.
Benefit is improved if used in conjunction with a comprehensive support and counselling program.
Note:
No increase in the maximum quantity or number of units may be authorised.
Note:
No increase in the maximum number of repeats may be authorised.

5465P Nicotine, nicotine 21 mg/24 hours patch, 28 (Nicabate P)

5571F Nicotine, nicotine 21 mg/24 hours patch, 28 (Nicotinell Step 1)

10076H Nicotine, nicotine 25 mg/16 hours patch, 28 (nicorette 16hr Invisipatch)

 

Authority Required
Dermatophyte infection
Clinical criteria:
Patient must have failed to respond to topical treatment.
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.

2285G Terbinafine, terbinafine 250 mg tablet, 42 (various brands)

 

Authority required (STREAMLINED)
6434 Fungal or yeast infection
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.

9024Y Ketoconazole, ketoconazole 2% cream, 30 g (Nizoral 2% Cream)

9025B Ketoconazole, ketoconazole 1% shampoo, 100 mL  (Nizoral 1%)

1574W Ketoconazole, ketoconazole 2% shampoo, 60 mL (Nizoral 2%)

9027D Miconazole, miconazole nitrate 2% cream, 30 g  (Daktarin)

9028E Miconazole, miconazole nitrate 2% cream, 70 g (Daktarin)

9029F Miconazole, miconazole nitrate 2% dusting powder, 30 g (Daktarin)

9031H Miconazole, miconazole 2% solution, 30 mL (Daktarin)

1698J Nystatin, nystatin 100 000 units/g cream, 15 g (Mycostatin)

9160D Terbinafine, terbinafine hydrochloride 1% cream, 15 g (Lamisil)

 

Authority Required (STREAMLINED)
5139 Thiamine deficiency
Clinical criteria:
The treatment must be for prophylaxis.
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.

1070H THIAMINE, thiamine hydrochloride 100 mg tablet, 100 (Betavit)

 

Authority Required (STREAMLINED)
5817 Whipworm infestation
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.

9047E ALBENDAZOLE, albendazole 200 mg chewable tablet, 6 (Zentel)

 

Authority Required
Chronic suppurative otitis media
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person,
AND
Patient must be aged 1 month or older.

2480M  CIPROFLOXACIN, ciprofloxacin 0.3% ear drops, 5 mL (Ciloxan)

 

Authority Required (STREAMLINED)
5506 Hypomagnesaemia
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.
Authority Required (STREAMLINED)
5466 Chronic renal disease
Population criteria:
Patient must be an Aboriginal or a Torres Strait Islander person.

5146W MAGNESIUM ASPARTATE DIHYDRATE, magnesium aspartate dihydrate 500 mg (equivalent to 37.4 mg of magnesium) tablet, 50 (Mag-Sup, MagMin (PBS))

 

The following items have been retained on the PBS General Schedule for treatment of patients identifying as Aboriginal or Torres Strait Islander origin. This is a result of the measure to delist certain over-the-counter (OTC) drugs from the PBS as part of the PBS Access and Sustainability package of measures. More information on this measure can be found on the PBS Access and Sustainability Package including the Sixth Community Pharmacy Agreement (see Removal of PBS Subsidy for certain Low-Cost, Over-The-Counter Medicines at page 16). 

           

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

1010E ASPIRIN, aspirin 300 mg tablet: effervescent, 96 (Solprin)

5018D ASPIRIN, aspirin 300 mg tablet: effervescent, 96 (Solprin) (Dental)

8202Q ASPIRIN, aspirin 100 mg tablet, 112 (Spren 100)

 

Restricted benefit         
Constipation
Clinical criteria:
Patient must be paraplegic or quadriplegic or have severe neurogenic impairment of bowel function.

Restricted Benefit
Constipation
Clinical criteria:
Patient must be receiving palliative care.

Restricted Benefit
Constipation
Clinical criteria:
Patient must be receiving long-term nursing care on account of age, infirmity or other condition in a hospital, nursing home or residential facility.
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Constipation
Clinical criteria:
Patient must be receiving long-term nursing care and in respect of whom a Carer Allowance is payable as a disabled adult.
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Terminal malignant neoplasia
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Anorectal congenital abnormalities
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Megacolon
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.     

1258F BISACODYL, bisacodyl 10 mg suppository, 12 (Petrus Bisacodyl Suppositories)

1260H BISACODYL, bisacodyl 10 mg suppository, 10 (Dulcolax, Petrus Bisacodyl Suppositories)

 

Restricted benefit      
For treatment of a patient identifying as Aboriginal or Torres Strait Islander      
Note:
Each sachet contains sodium chloride 470 mg, potassium chloride 300 mg, sodium acid citrate 530 mg and glucose 3.56 g.

3196F SODIUM CHLORIDE + POTASSIUM CHLORIDE + GLUCOSE MONOHYDRATE + CITRATE, sodium chloride 470 mg + potassium chloride 300 mg + glucose monohydrate 3.56 g + sodium acid citrate 530 mg oral liquid: powder for, 10 x 4.9 g sachets (various brands)

 

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander       
Note
The 5 mg strength tablet should be used in malabsorption states only.

1437P FOLIC ACID, folic acid 5 mg tablet, 100 (Megafol 5)

 

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander       

2958Q FOLIC ACID, folic acid 500 microgram tablet, 100 (Foltabs 500, Megafol 0.5)

 

Restricted benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

3107M GLUCOSE AND KETONE INDICATOR URINE, glucose and ketone indicator urine strip: diagnostic, 50 diagnostic strips (Keto-Diastix)

3104J GLUCOSE INDICATOR URINE, glucose indicator urine strip: diagnostic, 50 diagnostic strips (Diastix)

 

Restricted Benefit        
Pernicious anaemia
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Proven vitamin B12 deficiencies other than pernicious anaemia
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Restricted Benefit
Anaemias associated with vitamin B12 deficiency
Clinical criteria:
Patient must have had a gastrectomy,
AND
The treatment must be for prophylaxis.
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

Note
One injection of hydroxocobalamin 1 mg every three months provides appropriate maintenance therapy in vitamin B12 deficiencies.
Note
Pharmaceutical benefits that have the form hydroxocobalamin injection 1 mg (as acetate) in 1 mL and pharmaceutical benefits that have the form hydroxocobalamin injection 1 mg (as chloride) in 1 mL are equivalent for the purposes of substitution.

2162T HYDROXOCOBALAMIN, hydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules (Vita-B12)

9048F HYDROXOCOBALAMIN, hydroxocobalamin 1 mg/mL injection, 3 x 1 mL ampoules (Neo-B12)

               

Restricted Benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

1746X PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane)

5196L PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane) (Dental)

               

Restricted Benefit        
Chronic arthropathies
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

5224Y PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane) (Dental)

8784H PARACETAMOL, paracetamol 500 mg tablet, 100 (APO-Paracetamol, Febridol, Generic Health Pty Ltd, Panamax, Paracetamol (Sandoz), Paralgin, Parapane)

               

Note
Pharmaceutical benefits that have the form paracetamol 665 mg tablet: modified release, 96 and pharmaceutical benefits that have the form paracetamol 665 mg tablet: modified release, 192 are equivalent for the purposes of substitution.
Restricted Benefit         
Persistent pain
Clinical criteria:
The condition must be associated with osteoarthritis.   
Population criteria:
Patient must identify as Aboriginal or Torres Strait Islander.

10797G PARACETAMOL, paracetamol 665 mg tablet: modified release, 192 tablets (Osteomol 665 Paracetamol)

8814X PARACETAMOL, paracetamol 665 mg tablet: modified release, 96 tablets (Osteomol 665 Paracetamol)

 

Restricted Benefit         
For treatment of a patient identifying as Aboriginal or Torres Strait Islander        

1747Y PARACETAMOL, paracetamol 120 mg/5 mL oral liquid, 100 mL (Panamax)

1770E PARACETAMOL, paracetamol 240 mg/5 mL oral liquid, 200 mL (Panamax 240 Elixir)

3348F PARACETAMOL, paracetamol 120 mg/5 mL oral liquid, 100 mL (Panamax) (Dental)

3349G PARACETAMOL, paracetamol 240 mg/5 mL oral liquid, 200 mL (Panamax 240 Elixir) (Dental)